Rare Kidney Tumors (Record no. 29570)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03377nam a22002897a 4500 |
| 001 - CONTROL NUMBER | |
| control field | 20241102135253.0 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20241102135759.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 241102b |||||||| |||| 00| 0 eng d |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER | |
| LC control number | 2018957321 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 978-3-319-96988-6 |
| International Standard Book Number | 978-3-319-96989-3 (eBook) |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | ddc |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | English |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Fuller form of name | Gabriel G. Malouf |
| 222 ## - KEY TITLE | |
| Key title | adults anaplasia associated bevacizumab bilateral ccRCC CDC patients cell RCC cell renal cell characterized chemotherapy Children's Oncology Group ChRCC chromophobe chromophobe renal cell chromosome clear cell renal clear-cell Clin Oncol COG collecting duct collecting duct carcinoma cytogenetic diagnosis differentiation doxorubicin epithelial everolimus fusion transcripts gemcitabine gene genetic genomic germline mutations grade histologic histologic subtype HLRCC HPRC imaging immunohistochemical kidney cancer lesions lung lymph node malignancies Malouf median metastasectomy metastatic metastatic disease molecular non-clear cell outcome papillary RCC papillary renal cell Pathology pathway patients with metastatic Pediatr phase pRCC prognostic factors RCC renal carcinoma renal cell carcinoma renal masses renal medullary carcinoma renal tumors reported resection risk RMC sarcomatoid component sarcomatoid renal cell sickle cell SIOP SMARCB1 sorafenib sporadic sRCC stage sunitinib Surg Pathol surgery surgical syndrome Tannir targeted therapy TFE3 TFEB translocation renal cell tRCC treatment tumor suppressor Urol VHL Wilms tumor WT XRT |
| 240 ## - UNIFORM TITLE | |
| Uniform title | Rare Kidney Tumors |
| 245 ## - TITLE STATEMENT | |
| Title | Rare Kidney Tumors |
| Remainder of title | Comprehensive Multidisciplinary Management and Emerging Therapies. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Department of Hematology and Oncology Strasbourg University Hospital Hopital Civil Strasbourg France | |
| Name of publisher, distributor, etc. | Springer Nature Switzerland AG | |
| Date of publication, distribution, etc. | 2019. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 131 Pages |
| Extent | Includes References |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | This book provides clinicians with clear guidance on treatment decision-making in patients with rare kidney cancers. After a brief review on epidemiology, pathology, and biology, each chapter focuses on the multidisciplinary management of a particular tumor subtype using the full range of available cancer therapy modalities, including surgery, radiotherapy, chemotherapy, targeted therapies, and immunotherapy. Emerging therapies and future directions in the management of each cancer subtype are also discussed. The chapters are all written by multidisciplinary teams of international experts comprising at least a urologist, a medical oncologist, and a pathologist.<br/><br/>Rare kidney cancers represent 15% of renal cell carcinomas. In comparison with clear cell renal cell carcinomas, little is known about the biology of such cancers, and few trials have reported on the efficacy of targeted therapies in the metastatic setting. Optimal management thus poses significant challenges and often requires a multidisciplinary team. This book will be an ideal reference guide for all clinicians involved in the care of patients with these orphan tumors. |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| General subdivision | Medical / Clinical Medicine, Medical / Oncology / General, Medical / Pediatrics, Medical / Urology, Oncology, Pediatrics, Urology, Kidneys -- Cancer -- Diseases, Medicine. |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Fuller form of name | Nizar M. Tannir |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1007/978-3-319-96989-3 ">https://doi.org/10.1007/978-3-319-96989-3 </a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | ddc |
| Koha item type | E-BOOKS |
| Suppress in OPAC | |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Total checkouts | Barcode | Date last seen | Copy number | Uniform resource identifier | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 11/02/2024 | 20241102135253.0 | 11/02/2024 | 20241102135253.0 | https://doi.org/10.1007/978-3-319-96989-3 | 11/02/2024 | E-BOOKS |